An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for AMPHASTAR PHARMACEUTICALS IN
| Ticker | AMPH |
| FIGI | BBG000BW90S6 |
| CUSIP | 03209R103 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 260 / 3.7% |
| Percentage held by institutional investors | 76.5% |
About
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. Wikipedia